Cellectar Biosciences: In Connection With The Reverse Stock Split, Every 30 Shares Of The Company’s Common Stock Issued And Outstanding As Of The Effective Time Will Be Automatically Converted Into One Share Of The Company’s Common Stock. Stockholders Who Would Otherwise Hold A Fractional Share Of Common Stock Will Receive A Cash Payment In Lieu Of Such Fractional Share, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Cellectar Biosciences, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***